X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...

Presentation Title: GT-02287, A Clinical-stage Allosteric GCase Modulator For The Treatment Of Parkinson's Disease, Protects Dopaminergic Neurons Against Mitochondrial Toxin MPP+ Presenter: Joanne ...

Credicorp's BCP leads Peru's banking sector with strong ROE, leveraging market share and low-cost deposits. See an analysis ...

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

The "Golden Age of Public Finance," as it was called by industry pundits, is likely to face significant changes under the ...

Donald Trump and his administration have waged an all-out assault on America's founding principles over the president's first 100 days in office.

Booking Health, the international medical tourism platform, offers new options for patients seeking the best prostate cancer care across top-rated hospitals and specialists globally. With a commitment ...

Across regional Penn State campuses, students prepare for final exams. Flowers bloom as commencement nears. Fear, anxiety and ...

Q1 2025 Earnings Call Transcript April 29, 2025 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.20352 ...

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, ...

Q1 2025 Earnings Conference Call April 30, 2025 11:30 AM ETCompany ParticipantsWade Walke - SVP, IRBrett Monia ...

The Achievement Cliff The Silicon Valley CEO had built a $400 million company but dreaded Monday mornings—he was on ...